{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:10:14Z","timestamp":1793693414295,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227010768"],"award-info":[{"award-number":["8227010768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017003","name":"Peking University Health Science Centre","doi-asserted-by":"publisher","award":["BMU2025PYJH015"],"award-info":[{"award-number":["BMU2025PYJH015"]}],"id":[{"id":"10.13039\/501100017003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252147"],"award-info":[{"award-number":["7252147"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtct.2026.02.061","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:01:35Z","timestamp":1772866895000},"page":"701.e1-701.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the Real-World Efficacy of Hetrombopag for the Treatment of Thrombocytopenia Postallogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"32","author":[{"given":"Rui","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jtct.2026.02.061_bib0001","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/17474086.2022.2125375","article-title":"Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective","volume":"15","author":"Ma","year":"2022","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10.1016\/j.jtct.2026.02.061_bib0002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","article-title":"Secondary failure of platelet recovery after hematopoietic stem cell transplantation","volume":"7","author":"Bruno","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.02.061_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1083-8791(00)70049-8","article-title":"A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation","volume":"6","author":"Nash","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.02.061_bib0004","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.22086","article-title":"Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant","volume":"86","author":"Zaja","year":"2011","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.02.061_bib0005","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbmt.2014.04.015","article-title":"Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Kong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.02.061_bib0006","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00277-016-2767-y","article-title":"Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Zhang","year":"2016","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.02.061_bib0007","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41409-022-01726-2","article-title":"Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children","volume":"57","author":"Wells","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.02.061_bib0008","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hon.2427","article-title":"Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: association with chronic graft-versus-host disease and survival outcome","volume":"36","author":"Akahoshi","year":"2018","journal-title":"Hematol Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.02.061_bib0009","first-page":"664","article-title":"[The kinetics and prognosis of platelet reconstitution after unmanipulated haploidentical stem cell transplantation without in vitro T cell depletion]","volume":"34","author":"Sun","year":"2013","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.jtct.2026.02.061_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/a-2673-4266","article-title":"Thrombocytopenia after hematopoietic stem cell transplantation in pediatrics and adults: a narrative review including etiology, management, monitoring, and novel therapies","volume":"52","author":"Kalantari","year":"2026","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"10.1016\/j.jtct.2026.02.061_bib0011","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.bbmt.2020.03.024","article-title":"Incidence, risk factors, and outcomes of primary prolonged isolated thrombocytopenia after haploidentical hematopoietic stem cell transplant","volume":"26","author":"Tang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.02.061_bib0012","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2009.10.004","article-title":"Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation","volume":"38","author":"Pr\u00e9bet","year":"2010","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2026.02.061_bib0013","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-021-01047-9","article-title":"A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia","volume":"14","author":"Mei","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.02.061_bib0014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00277-014-2158-1","article-title":"Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial","volume":"94","author":"Han","year":"2015","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.jtct.2026.02.061_bib0015","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/bmt.2011.179","article-title":"Romiplostim (AMG531, Nplate) for secondary failure of platelet recovery after allo-SCT","volume":"46","author":"Calmettes","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.02.061_bib0016","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/09537104.2018.1557613","article-title":"A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation","volume":"30","author":"Sun","year":"2019","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.jtct.2026.02.061_bib0017","first-page":"260","article-title":"Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation","volume":"3","author":"Poon","year":"2013","journal-title":"Am J Blood Res"},{"issue":"12","key":"10.1016\/j.jtct.2026.02.061_bib0018","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/bmt.2015.182","article-title":"Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation","volume":"50","author":"Battipaglia","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.02.061_bib0019","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1111\/petr.12325","article-title":"Successful treatment of post-transplant thrombocytopenia with romiplostim in a pediatric patient with X-linked chronic granulomatous disease","volume":"18","author":"Buchbinder","year":"2014","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.02.061_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12288-014-0491-0","article-title":"Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia","volume":"31","author":"Raut","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"10.1016\/j.jtct.2026.02.061_bib0021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12185-021-03153-3","article-title":"Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study","volume":"114","author":"Giammarco","year":"2021","journal-title":"Int J Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.02.061_bib0022","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41409-019-0435-2","article-title":"Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation","volume":"54","author":"Fu","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.02.061_bib0023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ctr.12673","article-title":"Characterization of thrombopoietin kinetics within 60 days after allogeneic hematopoietic stem cell transplantation and its correlation with megakaryocyte ploidy distribution","volume":"30","author":"Fu","year":"2016","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.02.061_bib0024","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03256939","article-title":"Safety of recombinant human thrombopoietin in adults after related donor haploidentical haematopoietic stem cell transplantation: a pilot study","volume":"31","author":"Liu","year":"2011","journal-title":"Clin Drug Investig"},{"issue":"5","key":"10.1016\/j.jtct.2026.02.061_bib0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bjh.13344","article-title":"Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant","volume":"169","author":"Labrador","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jtct.2026.02.061_bib0026","first-page":"935","article-title":"Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation","volume":"91","author":"Larocca","year":"2006","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.jtct.2026.02.061_bib0027","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1089\/scd.2010.0447","article-title":"Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study","volume":"20","author":"Liu","year":"2011","journal-title":"Stem Cells Dev"},{"issue":"5","key":"10.1016\/j.jtct.2026.02.061_bib0028","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1537-2995.2011.03400.x","article-title":"Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation","volume":"52","author":"S\u00e1nchez-Guijo","year":"2012","journal-title":"Transfusion"},{"issue":"14","key":"10.1016\/j.jtct.2026.02.061_bib0029","first-page":"964","article-title":"[Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation]","volume":"87","author":"Chen","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.jtct.2026.02.061_bib0030","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bjh.15119","article-title":"N-acetyl-L-cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post-allotransplant","volume":"180","author":"Kong","year":"2018","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jtct.2026.02.061_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.103205","article-title":"Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase \u2162 trial","volume":"9","author":"Mei","year":"2025","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726001806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726001806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:16:14Z","timestamp":1781212574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726001806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666636726001806"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.02.061","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Real-World Efficacy of Hetrombopag for the Treatment of Thrombocytopenia Postallogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.02.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}